Combined effects of interleukin-7 and stem cell factor administration on lymphopoiesis after murine bone marrow transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 1, 2011, Pages 48-60

  Chung, Brile ^a   Min, Dullei ^a   Joo, Lukas W ^b   Krampf, Mark R ^a   Huang, Jing ^a   Yang, Yujun ^a   Shashidhar, Sumana ^a   Brown, Janice ^a   Dudl, Eric P ^b   Weinberg, Kenneth I ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Interleukin 7; Murine bone marrow transplantation; Stem cell factor

Indexed keywords

RECOMBINANT INTERLEUKIN 7; STEM CELL FACTOR; INTERLEUKIN 7;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; LYMPHOID PROGENITOR CELL; LYMPHOPOIESIS; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; T CELL DEPLETION; THYMOPOIESIS; ANIMAL; CELL PROLIFERATION; CYTOLOGY; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; HUMAN; IMMUNE SYSTEM; METHODOLOGY; PHYSIOLOGY; THYMUS; TREATMENT OUTCOME;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; IMMUNE SYSTEM; INTERLEUKIN-7; LYMPHOPOIESIS; MICE; STEM CELL FACTOR; THYMUS GLAND; TREATMENT OUTCOME;

EID: 79956212679     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.07.027     Document Type: Article

References (56)

1. Socié G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med. 1999;341:14-21.
2. Ochs L, Shu XO, Miller J, et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood. 1995; 86:3979-3986.
3. Parkman R, Weinberg K. Immunological reconstitution following hematopoietic stem cell transplantation. In: Thomas ED, Blume KG, Forman SJ, editors. Hematopoietic Stem Cell Transplantation, 2nd ed. Oxford, UK: Blackwell; 1999 p. 704-711.
4. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690-695.
5. Chung B, Barbara-Burnham L, Barsky L, et al. Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood. 2001;98:1601-1606.
6. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD41 T-cell regeneration after intensive chemotherapy. N Engl J Med. 1995;332:143-149.
7. Hakim FT, Memon SA, Cepeda R, et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest. 2005;115:930-939.
8. Min D, Taylor PA, Panoskaltsis-Mortari A, et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood. 2002;99: 4592-4600.
9. Chung B, Dudl EP, Min D, et al. Prevention of graft-versus-host disease by anti-IL-7R alpha antibody. Blood. 2007;110:2803-2810.
10. Shinha ML, Fry TJ, Fowler DH, et al. Interleukin 7 worsens graft-versus-host disease. Blood. 2002;100:2642-2649.
11. Alpdogan O, Hubbard VM, Smith OM, et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood. 2006;107:2453-2460.
12. Weinberg K, Blazar BR, Wagner JE, et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001;97:1458-1466.
13. Small TN, Papadopoulos EB, Boulad F, et al. Comparison of immune reconstitution after unrelated and related T-cell- depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood. 1999;93:467-480.
14. Rossi S, Blazar BR, Farrell CL, et al. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood. 2002;100: 682-691.
15. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med. 1998;339:1186-1193.
16. Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997;90: 1345-1364.
17. Murray R, Suda T, Wrighton N, et al. IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. Int Immunol. 1989;169:707-716.
18. Pechon JJ, Morrissey PJ, Grabstein KH, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor- deficient mice. J Exp Med. 1994;180:1955-1960.
19. Somberg R, Robinson JP, Felsburg P. Tlymphocyte development and function in dogs with X-linked severe combined immune deficiency. J Immunol. 1994;153:4006.
20. Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin 2 receptor g chain mutation results in X-linked severe combined immune deficiency in humans. Cell. 1993;73:147.
21. Puel A, Ziegler SF, Buckley RH, et al. Defective IL7R expression in T(2)B(1)NK(1) severe combined immunodeficiency. Nat Genet. 1998;20:394-397.
22. Bolotin E, Smogorzewska M, Smith S, et al. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin- Blood. 1996;88:1887-1894.
23. Mackall CL, Fry TJ, Bare C, et al. IL-7 increases both thymicdependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood. 2001;97:1491-1497.
24. Sportes C, Hakim FT, Memon SA, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of nai{dotless}̈ve T cell subsets. J Exp Med. 2008;205:1701-1714.
25. Rosenberg SA, Sportes C, Ahmadzadeh M, et al. IL-7 administration to humans leads to expansion of CD81 and CD41 cells but a relative decrease of CD41 T-regulatory cells. J Immunother. 2006;29:313-319.
26. Rodewald HR, Kretzschmar K, Swat W, et al. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity. 1995; 3:313-319.
27. Godfrey DI, Zlotnik A, Suda T. Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J Immunol. 1992;149:2281-2285.
28. Massa S, Balciunaite G, Ceredig R, et al. Critical role for c-kit (CD117) in T cell lineage commitment and early thymocyte development in vitro. Eur J Immunol. 2006;36:526-532.
29. WuH, KlingmullerU, Besmer P, et al. Interaction of the erythropoietin and stem-cell factor receptors. Nature. 1995;377:242-246.
30. Liu L, Cutler RL, Mui AL, et al. Steel factor stimulates the serine/threonine phosphorylation of the interleukin-3 receptor. J Biol Chem. 1994;269:1677-1679.
31. Rodewald H-R, Ogawa M, Haller C, et al. Pro-thymocyte expansion by c-kit and the common cytokine receptor g chain is essential for repertoire formation. Immunity. 1997;6:265-272.
32. Jahn T, Sindhu S, Gooch S, et al. Direct interaction between Kit and the interleukin-7 receptor. Blood. 2007;110:1840-1847.
33. Toyama A, Chung B, Brown J, et al. Essential roles for IL-7 and c-kit signaling pathways in fetal and post-natal thymopoiesis. Manuscript in preparation.
34. Sportoletti P, Del Papa B, De Ioanni M, et al. Interleukin-7- engineered mesenchymal cells: in vitro effects on nai{dotless}̈ve T-cell population. Biol Blood Marrow Transplant. 2006;12:1250-1260.
35. Di Ianni M, Papa BD, De Ioanni M, et al. Interleukin 7- engineered stromal cells: a new approach for hastening nai{dotless}̈ve T cell recruitment. Hum Gene Ther. 2005;16:752-764.
36. Devine SM, Hoffman R. Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Hematol. 2000;7:358-363.
37. Nolta JA, Hanley MB, Kohn DB. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood. 1994; 83:3041-3051.
38. Ren YX, Finckenstein FG, Abdueva DA, et al. Mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. Cancer Res. 2008;68:6587-6597.
39. Morrissey PJ, McKenna H, Widmer MB, et al. Steel factor (c-kit ligand) stimulates the in vitro growth of immatureCD32/CD42/ CD82 thymocytes: synergy with IL-7. Cells Immunol. 1994;157: 118-131.
40. Kees UR, Ford J. Synergistic action of stem cell factor and interleukin-7 in a human immature T-cell line. Immunology. 1999;96:202-206.
41. Schimitt C, Ktorza S, Sarun S, et al. CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential. Blood. 1993;82: 3675-3685.
42. Sanchez M, Alfani E, Migiaccio AR, et al. Amplification of T cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7, and interleukin-2. Bone Marrow Transplant. 2003;31:713-723.
43. Akashi K, Weissman IL. The c-kit1 maturation pathway in mouse thymic T cell development: lineages and selection. Immunity. 1996;147-161.
44. Martin CH, Aifantis I, Scimone ML, et al. Efficient thymic immigration of B2201 lymphoid-restricted bone marrow cells with T precursor potential. Nat Immunol. 2003;4:866-873.
45. Bhandoola A, von Boehmer H, PetrieHT, et al. Commitment and development potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity. 2007;26:678-689.
46. Krueger A, Garbe Al, von Boehmer H. Phenotypic plasticity of T cell progenitors upon exposure to Notch ligands. J Exp Med. 2006;203:1977-1984.
47. Arber C, BitMansour A, Sparer TE, et al. Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood. 2003;102:421-428.
48. Bodine DM, Seidel NE, Zsebo KM, et al. In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood. 1993;82:445-455.
49. Dudl E, Chung B, Arber C, et al. Effects of common gamma and kit signals on lymphohematopoietic populations in vivo. Manuscript in preparation.
50. Fahlman C, Blomhoff HK, Veiby OP, et al. Stem cell factor and interleukin-7 synergize to enhance early myelopoiesis in vitro. Blood. 1994;84:1450-1456.
51. Zlotoff DA, Schwarz BA, Bhandoola A. The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man. Semin Immunopathol. 2008;30: 371-382.
52. Noort WA, Kruisselbrink AB, int't Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(1) cells in NOD/SCID mice. Exp Hematol. 2002;30:870-878.
53. Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy. 2009;11:503-515.
54. Le Blanc K, Samuelsson H, Gustafsson B, et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia. 2007;21:1733-1738.
55. Le Blanc K, Ringden O. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr Opin Immunol. 2006;18:586-591.
56. Chung B, Dudl E, Toyama A, et al. IL-7 is necessary for the development of experimental graft-versus-host disease. Biol Blood Marrow Transplant. 2008;14:16-27.